Resolution Therapeutics Announces £63.5 Million Series B …
Oct 3, 2024 · The proceeds from the Series B financing will be used to advance Resolution's lead candidate, RTX001, an autologous, engineered, pro-regenerative macrophage cell therapy …
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · The proceeds from the Series B financing will be used to advance Resolution's lead candidate, RTX001, an autologous, engineered, pro-regenerative macrophage cell therapy …
prnewswire.com
OFF
Resolution Therapeutics Raises £63.5 Million In Series B Financing …
6 days from now
Oct 3, 2024 · The Series B financing brings the total amount raised by Resolution to £101.4 million. Following the drawdown of the full Series B financing, Syncona's ownership stake in …
pharmiweb.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …
resolution-tx.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the …
yahoo.com
OFF
Syncona Ploughs £63.5m Into Resolution Therapeutics
6 days from now
Oct 3, 2024 · Syncona has committed £63.5m in a Series B financing of Resolution Therapeutics, a company focused on unlocking the regenerative potential of macrophage therapy for the …
theaic.co.uk
OFF
Resolution’s £64M Series B To Advance Macrophage Cell Therapy
6 days from now
Oct 3, 2024 · A preview of the next edition of BioWorld, Oct. 3, 2024. Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX …
bioworld.com
OFF
Resolution Therapeutics Raises £63.5M In Series B Funding
6 days from now
Oct 3, 2024 · NEW YORK – Resolution Therapeutics on Thursday said it has raised £63.5 million ($83.3 million) in Series B financing led by Syncona. Edinburgh, UK-based Resolution will use …
precisionmedicineonline.com
OFF
Resolution Therapeutics Secures £63.5 Million Funding Round
6 days from now
Oct 3, 2024 · Resolution Therapeutics, a forward-thinking and innovative biopharmaceutical company based in the vibrant cities of Edinburgh, Scotland, and London, UK, has successfully …
startupmag.co.uk
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …
epicos.com
OFF
Resolution Therapeutics - Unlocking Regenerative Macrophage …
6 days from now
Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment. Resolution raises £63.5M series B financing from Syncona and appoints Paul Sekhri as Chair …
resolution-tx.com
OFF
Edinburgh’s Resolution Therapeutics Raises £63m
6 days from now
Oct 3, 2024 · Edinburgh-based Resolution Therapeutics Limited announced it has raised £63.5 million in Series B financing round led by investment firm Syncona Ltd. Resolution is a clinical …
scottishfinancialreview.com
OFF
Resolution Scores $83m To Develop Macrophage Cell Therapies
6 days from now
Oct 3, 2024 · Resolution Therapeutics has raised £63.5m ($83.3m) in a Series B financing round to develop its macrophage cell therapies. The UK-based company plans to use the money to …
pharmaceutical-technology.com
OFF
Resolution Therapeutics Raises £63.5M In Series B Financing
6 days from now
Oct 3, 2024 · Resolution Therapeutics, an Edinburgh, Scotland, and London, UK-based clinical-stage biopharmaceutical company, raised £63.5M in Series B funding.. The round was led by …
finsmes.com
OFF
Resolution Therapeutics Secures £63.5 Million Funding And New …
6 days from now
Oct 3, 2024 · Resolution Therapeutics Limited, a pioneering clinical-stage biopharmaceutical company, has successfully raised £63.5 million in a notable Series B financing round. This …
investorshangout.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 4, 2024 · Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the …
pharmajournalist.com
OFF
Resolution Therapeutics Secures $63.5 Million In Series B Funding …
6 days from now
Resolution Therapeutics, a pioneering biotechnology company based at the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, has successfully raised an …
leadsontrees.com
OFF
Resolution Therapeutics Raised £63.5 Million In Series B Financing …
6 days from now
Sep 6, 2024 · Resolution Therapeutics raised £63.5 million in Series B financing led by Syncona. Go. ... Resolution Therapeutics raised £63.5 million in Series B financing led by Syncona. …
nordic9.com
FAQs about Resolution Therapeutics Announces £63.5 Million Series B … Coupon?
What is resolution Therapeutics?
Is resolution a regenerative biopharmaceutical company?
How much did resolution raise in Series B financing?
What is resolution's lead candidate therapy?
Who financed resolution & appoints Paul Sekhri?
What is the clinical development program for rtx001?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
